Does FOSCARNET Cause Myelosuppression? 120 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Myelosuppression have been filed in association with FOSCARNET (Foscarnet Sodium). This represents 5.8% of all adverse event reports for FOSCARNET.
120
Reports of Myelosuppression with FOSCARNET
5.8%
of all FOSCARNET reports
72
Deaths
83
Hospitalizations
How Dangerous Is Myelosuppression From FOSCARNET?
Of the 120 reports, 72 (60.0%) resulted in death, 83 (69.2%) required hospitalization, and 3 (2.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARNET. However, 120 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARNET Cause?
Off label use (610)
Drug ineffective (368)
Drug resistance (309)
Acute kidney injury (246)
Cytomegalovirus infection (200)
Nephropathy toxic (198)
Pathogen resistance (190)
Renal impairment (184)
Pancytopenia (170)
Cytomegalovirus infection reactivation (167)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which FOSCARNET Alternatives Have Lower Myelosuppression Risk?
FOSCARNET vs FOSFOMYCIN
FOSCARNET vs FOSFOMYCIN TROMETHAMINE
FOSCARNET vs FOSINOPRIL
FOSCARNET vs FOSPHENYTOIN
FOSCARNET vs FOSTAMATINIB